Gavin Giovannoni Selected Research

Interferon-beta

1/2015	Do neutralising antibodies against exogenous interferon-beta inhibit endogenous signalling pathways?
5/2011	Promising emerging therapies for multiple sclerosis.
10/2010	Current and future role of interferon beta in the therapy of multiple sclerosis.
7/2010	Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis.
3/2009	The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL.
7/2008	Validating parameters of a luciferase reporter gene assay to measure neutralizing antibodies to IFNbeta in multiple sclerosis patients.
7/2007	Neutralising antibodies to interferon beta in multiple sclerosis : expert panel report.
6/2007	Measuring and management of anti-interferon beta antibodies in subjects with multiple sclerosis.
5/2005	Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis.
1/2004	Neutralising antibodies against interferon beta in multiple sclerosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gavin Giovannoni Research Topics

Disease

209	Multiple Sclerosis 05/2024 - 10/2002
60	Relapsing-Remitting Multiple Sclerosis 01/2024 - 09/2003
16	Infections 03/2024 - 02/2012
16	Chronic Progressive Multiple Sclerosis 09/2022 - 09/2003
16	Disease Progression 10/2019 - 10/2004
12	COVID-19 02/2023 - 01/2020
10	Inflammation (Inflammations) 10/2023 - 05/2005
10	Atrophy 01/2022 - 12/2010
10	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2017 - 05/2005
9	Demyelinating Diseases (Demyelinating Disease) 06/2022 - 04/2003
8	Lymphopenia (Lymphocytopenia) 07/2021 - 02/2010
7	Autoimmune Diseases (Autoimmune Disease) 07/2023 - 04/2007
6	Progressive Multifocal Leukoencephalopathy 04/2023 - 04/2010
6	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2022 - 01/2010
6	Neoplasms (Cancer) 01/2020 - 01/2017
6	Movement Disorders (Movement Disorder) 11/2014 - 08/2004
5	Infectious Mononucleosis (Glandular Fever) 09/2023 - 01/2009
5	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2020 - 03/2014
5	Nervous System Diseases (Neurological Disorders) 11/2014 - 11/2006
5	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 05/2012 - 08/2004
5	Chorea (Rheumatic Chorea) 04/2009 - 03/2003
4	Neuroinflammatory Diseases 01/2023 - 01/2011
4	Headache (Headaches) 12/2022 - 11/2014
4	Herpes Zoster 04/2019 - 02/2010
4	Parkinson Disease (Parkinson's Disease) 01/2018 - 05/2008
4	Streptococcal Infections (Streptococcal Infection) 05/2012 - 08/2004
3	Chronic Disease (Chronic Diseases) 12/2022 - 02/2012
3	Epstein-Barr Virus Infections 01/2022 - 06/2007
3	Hypersensitivity (Allergy) 01/2019 - 03/2006
3	Chickenpox 01/2019 - 01/2009
3	Neuromyelitis Optica (Devic's Disease) 01/2019 - 01/2011
3	Optic Neuritis (Retrobulbar Neuritis) 03/2016 - 06/2008
3	Encephalitis (Encephalitis, Rasmussen) 08/2010 - 01/2004
2	Neutropenia 12/2023 - 11/2017
2	Craniocerebral Trauma (Head Injury) 09/2023 - 12/2012
2	Obesity 09/2023 - 01/2020
2	Rheumatoid Arthritis 08/2021 - 07/2012
2	Nausea 07/2021 - 09/2012
2	Opportunistic Infections (Opportunistic Infection) 04/2019 - 11/2018
2	Urinary Tract Infections (Urinary Tract Infection) 01/2019 - 07/2016
2	Meningitis 01/2019 - 08/2010
2	Human Influenza (Influenza) 01/2019 - 01/2004
2	HIV Infections (HIV Infection) 08/2018 - 01/2015
2	Vitamin D Deficiency 02/2018 - 07/2013
2	Hypertension (High Blood Pressure) 01/2018 - 12/2012

Drug/Important Bio-Agent (IBA)

42	Cladribine FDA LinkGeneric 05/2024 - 02/2010
31	TabletsIBA 05/2024 - 02/2010
29	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2006
29	AntibodiesIBA 12/2022 - 11/2003
21	Alemtuzumab (Campath)FDA Link 01/2024 - 03/2012
19	Natalizumab (Tysabri)FDA Link 04/2023 - 03/2006
16	Fingolimod Hydrochloride (FTY720)FDA Link 09/2023 - 07/2011
16	Dimethyl FumarateIBA 01/2023 - 09/2012
14	InterferonsIBA 01/2023 - 09/2004
13	Monoclonal AntibodiesIBA 02/2024 - 03/2012
13	Vitamin D FDA LinkGeneric 09/2023 - 06/2007
13	Interferon beta-1a FDA Link 01/2018 - 10/2004
12	Interferon-betaIBA 01/2015 - 09/2003
10	ocrelizumabIBA 01/2024 - 01/2017
9	Proteins (Proteins, Gene)FDA Link 01/2024 - 12/2008
8	VaccinesIBA 03/2024 - 06/2020
8	GadoliniumIBA 02/2024 - 07/2006
8	siponimodIBA 09/2022 - 02/2017
8	Daclizumab (Zenapax)FDA Link 10/2020 - 06/2013
8	CannabinoidsIBA 08/2017 - 05/2003
7	Neutralizing AntibodiesIBA 12/2022 - 06/2007
6	Immunoglobulin G (IgG)IBA 01/2023 - 01/2003
6	AntigensIBA 11/2021 - 05/2005
5	Sphingosine-1-Phosphate ReceptorsIBA 01/2023 - 07/2011
5	HLA-DRB1 Chains (HLA DRB1)IBA 10/2020 - 01/2010
4	Rituximab (Mabthera)FDA Link 12/2023 - 03/2016
4	COVID-19 VaccinesIBA 01/2023 - 01/2021
4	Neuroprotective AgentsIBA 01/2020 - 01/2013
4	Glatiramer Acetate (Copaxone)FDA Link 02/2017 - 05/2005
4	EnzymesIBA 07/2016 - 03/2006
4	daclizumab HYPIBA 05/2014 - 06/2013
3	Glial Fibrillary Acidic ProteinIBA 01/2024 - 01/2021
3	ofatumumab FDA Link 01/2024 - 10/2022
3	CytokinesIBA 12/2023 - 01/2013
3	teriflunomideIBA 10/2023 - 11/2014
3	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 10/2019
3	Indicators and Reagents (Reagents)IBA 08/2021 - 12/2014
3	Oligoclonal BandsIBA 10/2019 - 04/2003
3	AutoantibodiesIBA 05/2015 - 03/2003
3	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 06/2013 - 08/2010
2	Blood Proteins (Serum Proteins)IBA 01/2024 - 12/2010
2	Granzymes (Granzyme)IBA 01/2024 - 01/2017
2	Antiviral Agents (Antivirals)IBA 01/2023 - 12/2022
2	opicinumabIBA 02/2022 - 01/2019
2	Biotin (Vitamin H)FDA Link 02/2022 - 12/2020
2	Cytidine Diphosphate (CDP)IBA 01/2022 - 12/2018
2	AutoantigensIBA 11/2021 - 03/2006
2	RNA (Ribonucleic Acid)IBA 10/2020 - 01/2004
2	Transaminases (Aminotransferases)IBA 01/2018 - 09/2012

Therapy/Procedure

71	Therapeutics 03/2024 - 11/2003
10	Immunotherapy 03/2024 - 05/2005
2	Stem Cell Transplantation 01/2024 - 12/2023
2	Drug Therapy (Chemotherapy) 12/2023 - 12/2010
2	Injections 12/2022 - 05/2018
2	Precision Medicine 11/2021 - 11/2017